RSS

impurity

A licensing and supply agreement has been signed by Gyros Protein Technologies and Cygnus Technologies for the development of immunoassay kits for biotherapeutic impurity analysis. more

News

Some medicines containing valsartan used for the treatment of high blood pressure and heart conditions are being recalled across Europe to be reviewed by the European Medicines Agency (EMA) to determine the extent of ingredient impurity. more

News